Expression of proglucagon and proglucagon-derived peptide hormone receptor genes in the chicken.
To better understand how the proglucagon system functions in birds, we utilized a molecular cloning strategy to sequence and characterize the chicken proglucagon gene that encodes glucagon, glucagon-like peptide (GLP)-1 and GLP-2. This gene has seven exons and six introns with evidence for an additional (alternate) first exon and two promoter regions. We identified two distinct classes of proglucagon mRNA transcripts (PGA and PGB) produced by alternative splicing at their 3'-ends. These were co-expressed in all tissues examined with pancreas and proventriculus showing the highest levels of each. Although both mRNA classes contained coding sequence for glucagon and GLP-1, class A mRNA lacked that portion of the coding region (CDS) containing GLP-2; whereas, class B mRNA had a larger CDS that included GLP-2. Both classes of mRNA transcripts exhibited two variants, each with a different 5'-end arising from alternate promoter and alternate first exon usage. Fasting and refeeding had no effect on proglucagon mRNA expression despite significant changes in plasma glucagon levels. To investigate potential differences in proglucagon precursor processing among tissues, mRNA expression for two prohormone convertase (PC) genes was analyzed. PC2 mRNA was predominantly expressed in pancreas and proventriculus, whereas PC1/3 mRNA was more highly expressed in duodenum and brain. We also determined mRNA expression of the specific receptor genes for glucagon, GLP-1 and GLP-2 to help define major sites of hormone action. Glucagon receptor mRNA was most highly expressed in liver and abdominal fat, whereas GLP-1 and GLP-2 receptor genes were highly expressed in the gastrointestinal tract, brain, pancreas and abdominal fat. These results offer new insights into structure and function of the chicken proglucagon gene, processing of the precursor proteins produced from it and potential activity sites for proglucagon-derived peptide hormones mediated by their cognate receptors.
Richards
Mark P
MP
Animal Biosciences and Biotechnology Laboratory, USDA, ARS, Animal and Natural Resources Institute, Beltsville Agricultural Research Center, BARC-East, Beltsville, MD 20705-2350, USA. Mark.Richards@ars.usda.gov
McMurtry
John P
JP
D000595:Amino Acid Sequence; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D053801:Capillary Electrochromatography; D002645:Chickens / Q000235:genetics* / Q000502:physiology*; D003001:Cloning, Molecular; D017931:DNA Primers; D005091:Exons / Q000235:genetics; D000067757:Glucagon-Like Peptide-1 Receptor; D007438:Introns / Q000235:genetics; D008297:Male; D008969:Molecular Sequence Data; D021141:Nucleic Acid Amplification Techniques; D052336:Proglucagon / Q000096:biosynthesis* / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000235:genetics; D043484:Proprotein Convertases / Q000096:biosynthesis / Q000235:genetics; D011498:Protein Precursors / Q000096:biosynthesis / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D018027:Receptors, Glucagon / Q000096:biosynthesis* / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013050:Spectrometry, Fluorescence
D001786:Blood Glucose; D017931:DNA Primers; D000067757:Glucagon-Like Peptide-1 Receptor; D011498:Protein Precursors; D012333:RNA, Messenger; D018027:Receptors, Glucagon; D052336:Proglucagon; D043484:Proprotein Convertases